{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:35:08Z","timestamp":1768484108998,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.cca.2007.02.011","type":"journal-article","created":{"date-parts":[[2007,2,16]],"date-time":"2007-02-16T07:20:46Z","timestamp":1171610446000},"page":"186-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Alterations in serum amino acid concentrations in male and female schizophrenic patients"],"prefix":"10.1016","volume":"380","author":[{"given":"Masayuki","family":"Tomiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihisa","family":"Fujisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Iyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Mitsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Toyo'oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2007.02.011_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archpsyc.60.6.565","article-title":"Sex differences in the risk of schizophrenia","volume":"60","author":"Aleman","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.cca.2007.02.011_bib2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/ps.2006.57.6.844","article-title":"Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders","volume":"57","author":"Grossman","year":"2006","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.cca.2007.02.011_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00737-002-0003-3","article-title":"Oestrogen effects in schizophrenia and their potential therapeutic implications \u2014 review","volume":"5","author":"Riecher-Rossler","year":"2002","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.cca.2007.02.011_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.schres.2004.06.013","article-title":"Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics","volume":"73","author":"Bergemann","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.cca.2007.02.011_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0920-9964(00)00088-8","article-title":"Estrogen \u2014 a potential treatment for schizophrenia","volume":"48","author":"Kulkarni","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.cca.2007.02.011_bib6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.cca.2007.02.011_bib7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.cca.2007.02.011_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/1573400054065569","article-title":"Dysfunction of glia-neuron communication in pathophysiology of schizophrenia","volume":"1","author":"Hashimoto","year":"2005","journal-title":"Curr Psychiatr Rev"},{"key":"10.1016\/j.cca.2007.02.011_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00702-004-0200-5","article-title":"Amino acids in schizophrenia: evidence for lower tryptophan availability during treatment with atypical antipsychotics?","volume":"112","author":"van der Heijden","year":"2005","journal-title":"J Neural Transm"},{"key":"10.1016\/j.cca.2007.02.011_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.euroneuro.2003.09.002","article-title":"Atypical antipsychotics and the relevance of glutamate and serotonin","volume":"14","author":"van der Heijden","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.cca.2007.02.011_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0304-3940(80)90178-0","article-title":"Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia","volume":"20","author":"Kim","year":"1980","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.cca.2007.02.011_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145703003900","article-title":"Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms","volume":"7","author":"Sumiyoshi","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.cca.2007.02.011_bib13","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1176\/appi.ajp.162.9.1738","article-title":"Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type","volume":"162","author":"Neeman","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.cca.2007.02.011_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000054937","article-title":"Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine","volume":"44","author":"Tortorella","year":"2001","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.cca.2007.02.011_bib15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/bmc.677","article-title":"Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-d-aspartate receptor antagonist, ketamine","volume":"20","author":"Tomiya","year":"2006","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.cca.2007.02.011_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0003-2670(01)93016-8","article-title":"Fluorimetric determination of secondary amino acids by 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole","volume":"130","author":"Imai","year":"1981","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.cca.2007.02.011_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/bmc.365","article-title":"A fully automated amino acid analyzer using NBD-F as a fluorescent derivatization reagent","volume":"18","author":"Aoyama","year":"2004","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.cca.2007.02.011_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0378-4347(95)00111-U","article-title":"Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated pre-column derivatization with o-phthaldialdehyde","volume":"669","author":"Fekkes","year":"1995","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.cca.2007.02.011_bib19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cca.2006.09.019","article-title":"Determination of kynurenic acid in human serum and its correlation with the concentration of certain amino acids","volume":"377","author":"Fukushima","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2007.02.011_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archpsyc.60.6.572","article-title":"Decreased serum levels of d-serine in patients with schizophrenia. Evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia","volume":"60","author":"Hashimoto","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.cca.2007.02.011_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0006-8993(97)00352-1","article-title":"Proline-induced potentiation of glutamate transmission","volume":"761","author":"Cohen","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.cca.2007.02.011_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1523\/JNEUROSCI.19-01-00021.1999","article-title":"The mammalian brain high-affinity l-proline transporter is enriched preferentially in synaptic vesicles in a subpopulation of excitatory nerve terminals in rat forebrain","volume":"19","author":"Renick","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.cca.2007.02.011_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.brainres.2005.12.064","article-title":"Immunohistochemical evidence for the localization of neurons containing the putative transmitter l-proline in rat brain","volume":"1073\u20131074","author":"Takemoto","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.cca.2007.02.011_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/syn.10286","article-title":"Catechol-O-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression","volume":"51","author":"Tunbridge","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.cca.2007.02.011_bib25","doi-asserted-by":"crossref","first-page":"16859","DOI":"10.1073\/pnas.232186099","article-title":"Genetic variation in the 22q11 locus and susceptibility to schizophrenia","volume":"99","author":"Liu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2007.02.011_bib26","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/nn1562","article-title":"Transcriptional and behavioural interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice","volume":"8","author":"Paterlini","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.cca.2007.02.011_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.schbul.a033326","article-title":"Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia","volume":"24","author":"Swerdlow","year":"1998","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.cca.2007.02.011_bib28","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/hmg\/11.19.2243","article-title":"PRODH mutations and hyperprolinaemia in a subset of schizophrenic patients","volume":"11","author":"Jacquet","year":"2002","journal-title":"Hum Mol Genet"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898107000782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898107000782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:41:29Z","timestamp":1757860889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898107000782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0009898107000782"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2007.02.011","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in serum amino acid concentrations in male and female schizophrenic patients","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2007.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}